CD45RA depleted donor lymphocyte infusion (DLI) clinical trials

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

This study is testing a new treatment called CD45RA depleted DLI for people with blood cancers after a stem cell transplant. It aims to see if it's safe and helps prevent the cancer from coming back.